Pilot Study to Evaluate the Effect of Ketotifen on the Adverse Events Associated With Peanut Desensitization

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The primary objective of this study is to evaluate, compared to non-treatment, the impact of a titrated dose (1 mg once a day, then 1 mg twice a day and finally a full 2 mg twice a day) of ketotifen on the adverse event profile emerging from a rapid peanut desensitization protocol, in children with established peanut allergy.
Epistemonikos ID: ad989d632408cfbfcccae255458d7c4085955826
First added on: May 11, 2024